RCSD1

RCSD domain containing 1

Curated evidence

Clinical evidence (1)

CIViC items involving this gene, grouped by molecular profile and therapy, with native levels and directions. 50 items per page.

civicCuratedShowing 1–1 of 1 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.

Therapy	Cancer	Type	Level	Direction · significance	Rating (1–5)	Status	Evidence	Source
RCSD1 RCSD1::ABL11
Imatinib	Childhood B-cell Acute Lymphoblastic LeukemiaUNRESOLVED	Predictive	C	Supports Sensitivity Response	3	rejected	EID7782 In the case report, it has been stated that the patient with known B-cell precursor ALL was induced to remission by imatinib, a tyrosine kinase inhibitor that affects the following eight ABL1 fusion p… (full text at CIViC) PMID 27125982 · Perwein et al., 2016 · Open in CIViC	civic

Cohorts

Frequency = cases affected / cases profiled within one cohort. Cohorts are never pooled.

gdcObserved1 cohort row · frequency = affected / profiled, as published by each cohort; cohorts are not pooled. Hover a row badge for its release.

Cohort	Mapped cancer	Alteration	Affected (n)	Profiled (n)	Frequency (%)	Rank in cohort	Source
Burkitt Lymphoma Genome Sequencing Project CGCI-BLGSP	Burkitt Lymphoma	Ssm

Literature

Data not yet available

No publication linked to this gene yet.